NCT07089914

Brief Summary

The aim of Health Surveillance 2025 is to analyze and describe the state of health of employees at University of Applied Science Hamburg, key influencing factors and individual resources.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 14, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 29, 2025

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

July 22, 2025

Last Update Submit

August 11, 2025

Conditions

Keywords

Healthy employeesHealth literacyDisabilityAgeGenderwork characteristicsPHQ-4Self-efficacySatisfaction with Life Scale (SWLS)Subjective health statusJob satisfactionUCLA-LSHEI-Stress

Outcome Measures

Primary Outcomes (2)

  • Health literacy

    10 Items (Lenartz, Söllner \& Rudinger, 2014), Range 1 (does not apply/trifft überhaupt nicht zu) - 4 (does fully apply/trifft genau zu), higher scores mean a better outcome

    baseline

  • Loneliness

    University of California Los Angelese Loneliness Scale (UCLA-LS) - 3 Items (Schobin, Arriagada \& Gibson-Kunze, 2024), Range 1 (never/nie) - 5 (very often/sehr oft), higher scores mean a worse outcome

    Baseline

Secondary Outcomes (7)

  • Depression and anxiety

    baseline

  • Subjective health status

    baseline

  • Job satisfaction

    baseline

  • HEI-Stress

    baseline

  • Self-efficacy

    baseline

  • +2 more secondary outcomes

Other Outcomes (2)

  • Discriminiation

    baseline

  • Corporate Culture (MOLA)

    baseline

Study Arms (1)

employees

employees at University of Applied Science

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All University of Applied Sciences Hamburg employees who wish to take part in the study will be included. Inclusion criteria are germanEnglish language, reading and writing skills, internet access and employee status. Before the start of the survey period and directly before the start of the online survey, all participants will receive all relevant study information and actively declare their consent to participate in the study.

You may qualify if:

  • German language skills
  • Reading and writing skills
  • Internet access
  • Employee status
  • Consent to participate in the study

You may not qualify if:

  • Illiteracy
  • Massively limited cognitive abilities i.e. linguistic components of the digital offerings must be able to be used, and questionnaires completed, or interviews participated in)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hamburg University of Applied Sciences/Hochschule für Angewandte Wissenschaften Hamburg (HAW Hamburg)

Hamburg, 21033, Germany

Location

Related Links

MeSH Terms

Conditions

Social IsolationAnxiety DisordersHealth BehaviorLymphoma, FollicularCoitus

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorMental DisordersLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesSexual Behavior

Study Officials

  • Sonia Lippke, Prof. Dr.

    Constructor University Bremen gGmbH & HAW Hamburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2025

First Posted

July 29, 2025

Study Start

May 14, 2025

Primary Completion

July 30, 2025

Study Completion

December 31, 2025

Last Updated

August 12, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Due to data security regulations and the approved Data protection concept, sharing is not permitted by the authorities

Locations